THENATIONALPULSE (Pulse Wires) - More Pharma Firms Want to Make Drug Price Deals With Trump.
PULSE POINTSWHAT HAPPENED: Some pharmaceutical companies not directly contacted by the Trump administration to lower U.S. drug prices are seeking to craft their own agreements to avoid potential tariffs and price-setting programs.WHO WAS INVOLVED: The Trump administration, pharmaceutical companies including Bayer, Pfizer, Eli Lilly, and industry groups such as PhRMA and the Midsized Biotech Alliance […] The post More Pharma Firms Want to Make Drug Price Deals With Trump. appeared first on The National Pulse .
PULSE POINTS WHAT HAPPENED: Some pharmaceutical companies not directly contacted by the Trump administration to lower U.S. drug prices are seeking to craft their own agreements to avoid potential tariffs and price-setting programs. WHO WAS INVOLVED: The Trump administration, pharmaceutical companies including Bayer, Pfizer, Eli Lilly, and industry groups such as PhRMA and the Midsized Biotech Alliance of America. WHEN & WHERE: Ongoing discussions following directives issued by the Trump administration in the U.S.; recent comments made at the JP Morgan Healthcare Conference in San Francisco. KEY QUOTE: “The Trump administration, of course, wants to negotiate deals that meaningfully lower drug prices for American patients with every…Open